Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 187

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

CD19-CAR T-cell therapy induces deep tissue depletion of B cells

Open access
Tur, Carlo, Eckstein, Markus, Velden, Joachim, Rauber, Simon, Bergmann, Christina, Auth, Janina, Bucci, Laura, Corte, Giulia, Hagen, Melanie, Wirsching, Andreas, Grieshaber-Bouyer, Ricardo, Reis, Petra, Kittan, Nicolai, Wacker, Jochen, Rius Rigau, Aleix, Ramming, Andreas, D'Agostino, Maria-Antonietta, Hartmann, Arndt, Müller, Fabian, Mackensen, Andreas, Bozec, Aline, Schett, Georg, Raimondo, Maria Gabriella · 2025 · Annals of the Rheumatic Diseases

Abstract

Objectives CD19-targeting chimeric antigen receptor (CAR) T-cell therapy can induce long-term drug-free remission in patients with autoimmune diseases (AIDs). The efficacy of CD19-CAR T-cell therapy is presumably based on deep tissue depletion of B cells; however, such effect has not been proven in humans in vivo. Methods Sequential ultrasound-guided inguinal lymph node biopsies were performed at baseline and after CD19-CAR T-cell therapy in patients with AIDs. Results were compared with lymph node biopsies from rituximab (RTX)-treated AID patients with absence of peripheral B cells. Conventional and immunohistochemistry staining were performed on lymph node tissue to assess architecture as well the number of B cells, follicular dendritic cells (FDCs), plasma cells, T cells and macrophages. Results Sequential lymph node biopsies were analysed from five patients with AID before and after CD19-CAR T-cell therapy and from five patients with AID after RTX treatment. In addition, non-lymphoid organ biopsies (colon, kidney and gallbladder) from three additional patients with AID after CD19-CAR T-cell therapy were analysed. CD19+ and CD20+ B cells were completely depleted in the lymph nodes after CD19-CAR T-cell therapy, but not after RTX treatment. Plasma cells, T cells and macrophages in the lymph nodes remained unchanged. Follicular structures were disrupted and FDCs were depleted in the lymph nodes after CD19-CAR T-cell therapy, but not after RTX. Non-lymphoid organs were completely depleted of B cells. Discussion This study demonstrates complete B-cell depletion in secondary lymphoid tissues of patients with AIDs following CD19-CAR T-cell therapy combined with standard lymphodepleting therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/ard-2024-226142

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 187

Metadata

Authors
Tur, C., Eckstein, M., Velden, J., Rauber, S., Bergmann, C., Auth, J., Bucci, L., Corte, G., Hagen, M., Wirsching, A., Grieshaber-Bouyer, R., Reis, P., Kittan, N., Wacker, J., Rius Rigau, A., Ramming, A., D'Agostino, M.-A., Hartmann, A., Müller, F., Mackensen, A., Bozec, A., Schett, G., & Raimondo, M. G.
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2025-01
Volume
84
Issue
1
Pages
106-114
ISSN
0003-4967 (ISSN-L)
OpenAlex
W4401664751
Cited by
187
References
3
FWCI
28.70
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD19-CAR T-cell therapy induces deep tissue depletion of B cells. https://app.cochat.ai/papers/10.1136/ard-2024-226142
The paper
Tur, C., Eckstein, M., Velden, J., Rauber, S., Bergmann, C., Auth, J., Bucci, L., Corte, G., Hagen, M., Wirsching, A., Grieshaber-Bouyer, R., Reis, P., Kittan, N., Wacker, J., Rius Rigau, A., Ramming, A., D'Agostino, M.-A., Hartmann, A., Müller, F., . . . Raimondo, M. G. (2025). CD19-CAR T-cell therapy induces deep tissue depletion of B cells. Annals of the Rheumatic Diseases. https://doi.org/10.1136/ard-2024-226142

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.